Blood cancers
Identification of unfavorable or unintended sign, symptom, or disease temporally associated with the use of high dose methotrexate in children with cancer
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Kasturba medical collegeManipal, KarnatakaDirections ↗
Registry summary (technical)
Therapeutic safety assessment of high-dose methotrexate in pediatric hematolymphoid malignancies: an ambispective study - NIL
Sponsor: Manipal academy of higher education
CTRI/2025/06/089433 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026